We also examined various factors, including gene expression, survival status, DNA methylation, genetic alterations, immune infiltration, and relevant cellular pathways, to elucidate the possible molecular mechanisms underlying the involvement of LFNG, MFNG, and RFNG in the pathogenesis or clinical prognosis of different cancers. The gene discussed is RFNG; the disease is cancer.